Literature DB >> 32133998

Structure determination of the human TRPV1 ankyrin-repeat domain under nonreducing conditions.

Miki Tanaka1, Kaori Hayakawa1, Nozomi Ogawa2, Tatsuki Kurokawa2, Kenichi Kitanishi1, Kenji Ite1, Toshitaka Matsui3, Yasuo Mori2, Masaki Unno1.   

Abstract

TRPV1, a member of the transient receptor potential (TRP) channels family, has been found to be involved in redox sensing. The crystal structure of the human TRPV1 ankyrin-repeat domain (TRPV1-ARD) was determined at 4.5 Å resolution under nonreducing conditions. This is the first report of the crystal structure of a ligand-free form of TRPV1-ARD and in particular of the human homologue. The structure showed a unique conformation in finger loop 3 near Cys258, which is most likely to be involved in inter-subunit disulfide-bond formation. Also, in human TRPV1-ARD it was possible for solvent to access Cys258. This structural feature might be related to the high sensitivity of human TRPV1 to oxidants. ESI-MS revealed that Cys258 did not form an S-OH functionality even under nonreducing conditions.

Entities:  

Keywords:  TRPV1; akyrin-repeat domain; human; nonreducing conditions

Mesh:

Substances:

Year:  2020        PMID: 32133998      PMCID: PMC7057350          DOI: 10.1107/S2053230X20001533

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  41 in total

1.  TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: a key role for superoxide anion.

Authors:  Mahmoud M Khattab
Journal:  Eur J Pharmacol       Date:  2006-08-15       Impact factor: 4.432

2.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

3.  Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere.

Authors:  Jian Yu; Yong Zhou; Isao Tanaka; Min Yao
Journal:  Bioinformatics       Date:  2009-10-21       Impact factor: 6.937

4.  Hydrogen peroxide is a novel mediator of inflammatory hyperalgesia, acting via transient receptor potential vanilloid 1-dependent and independent mechanisms.

Authors:  Julie Elizabeth Keeble; Jennifer Victoria Bodkin; Lihuan Liang; Rachel Wodarski; Meirion Davies; Elizabeth Soares Fernandes; Carly de Faria Coelho; Fiona Russell; Rabea Graepel; Marcelo Nicolas Muscara; Marzia Malcangio; Susan Diana Brain
Journal:  Pain       Date:  2008-12-06       Impact factor: 6.961

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  TRPV3 is a calcium-permeable temperature-sensitive cation channel.

Authors:  Haoxing Xu; I Scott Ramsey; Suhas A Kotecha; Magdalene M Moran; Jayhong A Chong; Deborah Lawson; Pei Ge; Jeremiah Lilly; Inmaculada Silos-Santiago; Yu Xie; Peter S DiStefano; Rory Curtis; David E Clapham
Journal:  Nature       Date:  2002-06-23       Impact factor: 49.962

7.  Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification.

Authors:  Huai-hu Chuang; Stephanie Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

8.  Identification of species-specific determinants of the action of the antagonist capsazepine and the agonist PPAHV on TRPV1.

Authors:  Elsa Phillips; Alison Reeve; Stuart Bevan; Peter McIntyre
Journal:  J Biol Chem       Date:  2004-02-11       Impact factor: 5.157

Review 9.  Redox regulation of transient receptor potential channels.

Authors:  Daisuke Kozai; Nozomi Ogawa; Yasuo Mori
Journal:  Antioxid Redox Signal       Date:  2013-10-25       Impact factor: 8.401

10.  Heat-evoked activation of the ion channel, TRPV4.

Authors:  Ali Deniz Güler; Hyosang Lee; Tohko Iida; Isao Shimizu; Makoto Tominaga; Michael Caterina
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.